In this Issue
Clues For Identifying and Treating Retinal Vascular Disease
Medical Editor’s Page
By Allen C. Ho, MD, and Robert L. Avery, MD
Retina Today’s choice takeaways from this issue.
A breakdown of the types of audits retina practices can face.
By Sue Vicchrilli, COT, OCS, OCSR
At the Retina Fellows’ Forum, Lawrence P. Chong, MD, opened up about his life and work.
By Ferhina S. Ali, MD, MPH
A three- or five-trocar setup may be appropriate, depending on the severity of the infection.
By David R.P. Almeida, MD, MBA, PhD, and Eric K. Chin, MD
Epiretinal membrane peeling can improve vision; are we waiting too long?
By André V. Gomes, MD, PhD
By Yusuke Oshima, MD, PhD
The approval has stimulated research into gene therapies for other IRDs.
By Meghan J. DeBenedictis, MS, LGC, MEd, and Aleksandra V. Rachitskaya, MD
COVER FOCUS: ON THE CASE
Epidemiology, risk factors, and clinical features of this common cause of retinal vascular disease.
By Thomas Jenkins, MD; Daniel Su, MD; and Michael A. Klufas, MD
Management of this condition should take direction from clinical trial results.
By Nidhi Relhan, MD; William E. Smiddy, MD; and Delia Cabrera DeBuc, PhD
Strategies for treating RVO are more straightforward than those for RAO.